NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Enzymit

Enzymit

Private
Ness ZionaHealthcare & Life Scienceshttps://www.enzymit.com/

Last Round

Series A

Sep 25, 2024

Total Funding Raised

$15M

Company Overview

Enzymit is a biotechnology company that develops a cell-free bioproduction platform using AI-driven computational enzyme design to create novel enzymes for sustainable manufacturing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clean Manufacturing, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Infrastructure

Keywords

biomanufacturingcell-free synthesiscomputational enzyme designsynthetic biologysynbioenzymatic productionprotein engineeringsustainable chemistrygreen chemistryhyaluronic acidbiotech platformai-driven designingredient manufacturingtechnology licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Enzymit Comparables

Compare Enzymit with similar companies based on industry and business-model similarity.

Enzymit comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EnginZyme
85%
Debut
83%
Zymvol Biomodeling
82%

Enzymit Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 25, 2024
SeedApr 6, 2022
Pre SeedJul 1, 2020

Key People

Founding team and executive leadership

Gideon Lapidoth

Chief Executive Officer And Co-founder Of Enzymit

Founding Team

Enzymit Investors

Notable investors and investment history

Enzymit investors
InvestorRounds
Khosla VenturesSeries A
Grove VenturesSeries A
First Star VenturesSeries A, Seed
NextLeap VenturesSeed
Sapir Venture PartnersSeries A, Seed, Pre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 10, 2025

    First company to produce Hyaluronic Acid via enzymatic, cell-free process.

  • Oct 17, 2025

    Partnered with Cosun for cell-free Hyaluronic Acid production.

Enzymit Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Enzymit Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Enzymit's valuation, stock price, and market status.

Firmographic Details

HeadquartersNess Ziona
Employee Range27
Year Founded2020
Last FundingSep 25, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.